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Abstract: Purpose: Human amniotic epithelial cells (hAECs) are promising tools for endothelial repair in vascular regenerative medicine. We
hypothesized that these epithelial cells are capable of repairing the damaged endothelial layer following balloon injury of the carotid artery in adult
male rats.Results: Two days after injury, the transplanted hAECs were observed at the luminal side of the arterial wall. Then, 4 weeks after the injury,
signiﬁcant intimal thickening was observed in both untreated and cell implanted vessels. Constriction was decreased in both implanted and control
animals. Immunohistochemical analysis showed a few surviving cells in the intact arterial wall, but no cells were observed at the site of injury.
Interestingly, acetylcholine-induced dilation was preserved in the intact side and the sham-transplanted injured arteries, but it was a trend toward
decreased vasodilation in the hAECs’ transplanted vessels.Conclusion:We conclude that hAECs were able to incorporate into the arterial wall without
immunosuppression, but failed to improve vascular function, highlighting that morphological implantation does not necessarily result in functional
beneﬁts and underscoring the need to understand other mechanisms of endothelial regeneration.
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Introduction
Vascular injury leads to pathological repair and remodel-
ing that involve vascular smooth muscle cell migration
and proliferation, resulting in neointimal hyperplasia [1].
Endothelial cell loss is a major contributing factor to the
pathological repair of the injured blood vessel [2]. The
disruption of endothelial integrity leads to a concomitant
reduction in the production of vasculoprotective media-
tors, such as nitric oxide and prostacyclin, and increased
vasoconstrictor and growth-promoting factors resulting
in elevated vascular tone, platelet adhesion, enhanced
inﬂammation, and medial smooth muscle cell prolifera-
tion [3, 4]. The resultant neointimal hyperplasia is the
pathological basis for restenosis after revascularization
procedures, such as angioplasty, stenting, and bypass
grafting [1, 2]. Carbon monoxide, thalidomide, and
tamoxifen have been shown to reduce the neointimal
formation [5, 6], and stem cells and interleukin-1 recep-
tor antagonist were also applied in several investigations
to decrease the intimal hyperplasia [7–11]. Hybrid
biodegradable stents can accelerate re-endothelialization
[12], while endoglin antibody-coated stents can
inhibit neointimal formation of porcine coronary arteries
[13].
Because endothelial cell loss plays a pivotal role in the
pathogenesis of intimal hyperplasia after vascular injury,
we postulated that a therapeutic cell transplantation strat-
egy that promotes early re-endothelialization of the in-
jured vessels would inhibit intimal lesion development,
facilitate vascular repair, and improve long-term vessel
patency. Progenitor cells originating from the bone mar-
row have previously been isolated from the mononuclear
cell fraction of peripheral blood [14, 15]. These cells have
high proliferative potential [14] and differentiate into
endothelial cells under speciﬁc growth conditions [16],
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suggesting that they may be suitable sources for the re-
endothelialization of damaged vessels.
It has been recently shown that transplantation of
autologous circulating endothelial progenitor cells into
balloon-denuded arteries led to rapid re-endothelialization
of the injured artery [17]. Recently, the multipotent
differentiation ability of amnion-derived cells has been
reported [18, 19]. In the present study, we sought to
determine the viability of integrated human amniotic
epithelial cells (hAECs) in an animal model of arterial
injury by evaluating the effects of exogenous amniotic cell
transplantation in promoting re-endothelialization and
inhibition of neointimal hyperplasia after 4 weeks.
Methods
The authors of this manuscript have certiﬁed that they
comply with the principles of ethical publishing in Inter-
ventional Medicine & Applied Science: Szél Á, Merkely
B, Hüttl K, Gál J, Nemes B, Komo´csi A: Statement on
ethical publishing and scientiﬁc authorship [20].
Animal studies were carried out under the guidelines
of the ethical committee of Semmelweis University.
hAECs
Placentas were provided by the gynecological and pedi-
atric hospital in Linz and prepared as previously described
[21, 22]. The local ethical board approved the collection
of placentas. After cryopreservation in Cryo-SFM, hAECs
derived from 64 human amniotic membranes were
expanded in endothelial growth medium-2. The identity
of cells was conﬁrmed by analyzing speciﬁc cell surface
markers (CD14, CD34, CD45, CD49d, CD73, CD90,
and CD105) by ﬂow cytometry [23]. These markers
conﬁrm the lineage of hAEC86, but this marker proﬁle
is concordant for all hAECs including those used in the
present study. Furthermore, for the applied hAEC, we
evaluated the expression of CD31, CD54, CD106,
CD133, CD146, VEGFR2, and vWF (Fig. 1).
Cell staining
Two weeks before the experiments, the cells were washed
twice with phosphate-buffered saline (PBS), trypsinized,
and centrifuged in endothelial basal medium-2 (EBM-2)
at 1,200 rpm for 8 min. Then, the cells were counted and
500,000 cells/animal were transplanted as described
below (n= 3 animals). For short-term in vivo detection,
hAECs were labeled with the lipophilic membrane dye
Vybrant DiL (excitation 549 nm, emission 565 nm,
Molecular Probes) in a dilution of 1:200 for 30 min at
37 °C. After labeling, the cells were washed, centrifuged,
and injected immediately into three male Sprague-Daw-
ley rats. For long-term in vivo detection, injected cells
labeling the hAECs were cultured in EBM-2 containing
10mM5-bromo-2-deoxyuridine (BrdU) (Sigma-Aldrich,
B5002) (Fig. 2).
Rat carotid artery balloon angioplasty
Male Sprague-Dawley rats (400–450 g) were anesthe-
tized with 2-bromo-2-chloro-1,1,1-triﬂuoroethane
Fig. 1. Characterization of cells. The identity of cells was conﬁrmed by the presence of lineage-speciﬁc cell surface markers with ﬂow cytometry.
hAEC86 are negative for CD14, CD34, CD45, and CD49d, and positive for CD73, CD90, and CD105
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dinitrogen-monoxide (Halothane) in a mixture of O2 and
N2O (50%–50%). The right common, the right external,
and the right internal carotid arteries were isolated
through a cervical midline incision. After heparinization
through the internal jugular vein (150 IU/kg), hemo-
static controls were placed in the internal and external
carotid arteries. A 2F Fogarty embolectomy catheter
(Edwards Lifesciences Corporation, Irvine, CA, USA)
was inserted through the external branch into the com-
mon carotid artery to the aortic arch. The balloon was
withdrawn and rotated slowly while inﬂated to 1.6–
1.8 atm three times. After balloon denudation, 5 × 105
hAECs in 200 μl suspension were incubated in the
common carotid artery of six male Sprague-Dawley rats
for 30 min [24]. The external carotid was ligatured, and
blood ﬂow was restored through the internal carotid
artery. Animals were killed after 2 days to perform con-
focal microscopic study and after 4 weeks to perform the
measurement of vascular reactivity on isolated carotid
arteries and histologic studies.
Histology
Vessels were ﬁxed in situ by constant pressure ﬁxation at
100 mmHg with 10% formalin through a 22-gauge
butterﬂy angiocatheter placed in the abdominal aorta.
Three cell implanted rats and ﬁve control rats were used
in this experiment. Each carotid artery was embedded in
parafﬁn, and eight cross-sections were continuously cut
from all eight animals: four sections from the intact side
and four sections from the injured side. Parallel sections
were subjected to standard hematoxylin and eosin stain-
ing as well as to elastica Van Gieson staining and immu-
nohistochemistry. The formation of neointima was
expressed in the ratio of intima/media.
Fig. 2. BrdU labeled hAECs in vitro. Red color represents the nuclear Hoechst staining (Panel A). Green color represents the BrdU (Panel B).
Panel C shows the transmitted light. Co-localization of the red and green colors represents the successful BrdU labeling (white arrows,
Panel D). The image was taken at 20× magniﬁcation with ZEISS LSM 510 Meta confocal laser scanning microscope
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Immunohistochemistry
After deparafﬁnization, the sections were washed three
times with PBS. DNAse I (Sigma-Aldrich, Poole, UK)
was applied for DNA digestion. After the antigen retrieval
with Retrivagen A (BD Pharmingen, Basel, Switzerland)
and washing with PBS, the sections were blocked in
normal goat serum (Vector Laboratories, Burlingame,
CA, USA) for 1 h. The primary mouse anti-BrdU anti-
body (BD Pharmingen, Franklin Lakes, NJ) was solubi-
lized in blocking serum in a dilution of 1:200 and applied
overnight at 4 °C. After washing with PBS, Alexa Fluor
488 goat anti-mouse secondary antibody was used to
visualize the labeling (Molecular Probes, Invitrogen,
Carlsbad, CA, USA). Hoechst 33342 (Molecular Probes,
Eugene, Oregon, USA) was applied to counterstain
nuclei. To visualize the implanted hAECs in the blood
vessels, a Zeiss LSM 510 Meta confocal laser scanning
microscope (Carl Zeiss, Jena, Germany) was used with a
63× oil immersion objective.
Measurement of vascular reactivity on isolated carotid
arteries
Nine male Sprague-Dawley rats were used in sham group
(n = 3), in control group (n= 3), and in cell implanted
group (n= 3). The freshly harvested segments of arteries
were cut into 3–4 mm long ring segments and mounted
in organ baths ﬁlled with warmed (37 °C) and oxygenat-
ed (95%O2 and 5% CO2) Krebs’ solution (CaCl2 – 5mM;
MgSO4 – 1.17 mM; NaCl – 119 mM; NaHCO3 –
20 mM; KCl – 4.7 mM; KH2PO4 – 1.18 mM; Glucose –
11 mM; EDTA – 0.035 mM) as previously described [25].
A maximum of three segments were isolated from
each artery and on the whole, 37 segments were mea-
sured in this experiment. The state of arterial smooth
muscle was tested with K+-Krebs’ solution (NaCl – 0 mM;
KCl – 123.7 mM). Isometric tension was measured with
isometric transducers (Hottinger Baldwin Messtechnik,
Germany) and displayed on a data acquisition recorder
(Kipp & Zonen, Holland). A tension of 1.5 g was applied
and the rings were equilibrated for 60 min, followed by
measurements of dose-dependent contractility to epineph-
rine (10−10 to 3× 10−6 M). After another 60 min of
washing and equilibrating, concentration-dependent relax-
ation to acetylcholine (10−9 to 3× 10−4 M) and sodium
nitroprusside (10−8–10−5 M) was determined after precon-
traction with epinephrine (10−6 M). Experiments were
conducted in rings from 5–6 animals in each experimental
group.
Statistical analysis
Results are reported as mean ± SEM. Statistical signiﬁ-
cance was determined by t-test, two-way ANOVA, and
Newman–Keuls post-hoc tests, using GraphPad Prism
statistical software. Probability values of p< 0.0001,
p< 0.01, and p< 0.05 were considered signiﬁcant.
Results
Two days after balloon injury, the transplanted Vybrant
DiL-labeled hAECs were visible at the luminal side of the
arterial wall at the injured side (Fig. 3A), and no cells were
found in the intact contralateral side. Cells adhered to the
damaged intima, which were visible in three-dimensional
rendered microscopic images (Fig. 3B).
Four weeks after injury, signiﬁcant intimal thickening
was observed at the injured site in both study groups. The
percentage of intima thickness in the control group was
61.2± 4.1% compared to the intact side with 1.4± 0.1%
Fig. 3. Incorporation of hAECs into the vessel walls after 2 days of injury. Panel A shows an acute inﬁltration at the luminal side of the arterial wall
at the injured side. Red color represents the incorporated cells. Transplanted hAECs were stained with Vybrant DiL. Fresh vessel
preparations were used and were evaluated with confocal microscopy. The image was taken at 63× magniﬁcation. Panel B shows a 3D
structure Z-Stack image that conﬁrms the incorporation of transplanted cells (red)
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thickness (n= 41, p< 0.0001). Similar results were found
in the transplanted groups (cell implanted injured side:
53.1± 2.9%, cell implanted intact side 2.9± 1.0%, n=
40, p< 0.0001). There was a signiﬁcant difference be-
tween the injured and intact sides, but not between the
control and the transplanted groups.
Four weeks after transplantation, the injured arteries
showed a decreased constriction that was similar in
implanted and control animals. The uninjured contralat-
eral arteries had a similar constrictional capacity to sham-
operated animals (Fig. 4A).
Dilational capacity of the arteries was comparable in
each experimental group, with only the implanted
segments showing a trend toward decreased vasodila-
tion. There were signiﬁcant differences between cell
implanted intact and cell implanted injured groups
(Fig. 4B).
Four weeks after transplantation, cells labeled with
anti-BrdU antibody were observed at the intact arterial
side, where they incorporated into the walls of the blood
vessels (Fig. 5). Surprisingly, no incorporated cells were
found at the injured side at this time point.
Fig. 4. Effects of cell transplantation on the contraction and relaxation capacity of carotid arteries. (Panel A) The extent of contraction was similar
in the sham group and on the intact side of both cell transplanted and control groups. Contraction was greater on the intact side
compared to the injured side in both cell transplanted and control groups. Four weeks after injury, there was a signiﬁcant difference
between the intact and injured side in the transplanted groups. (Panel B) The injured endothelial layer had a decreased response to
acetylcholine stimulus in both groups that had angioplasty. The implantation of stem cells had signiﬁcant effect on the NO-dependent
relaxation of the injured vessels. Data are presented in mean± SEM (#), **: p< 0.01 and *: p< 0.05 cell implanted intact vs. cell
implanted injured
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Discussion
We successfully implanted hAECs into the vessel wall
after endothelial injury of carotid arteries. hAECs have
several beneﬁcial characteristics, such as low immunoge-
nicity and anti-inﬂammatory functions [26]; moreover,
they do not require the sacriﬁce of human embryos for
their isolation.
Although short-term implantation at 48 h was prom-
ising, the cells did not persist at the site of the injury and
the vascular dilational capacity was hardly modiﬁed. Our
hypothesis that hAECs can rebuild the endothelial layer
and decrease the thickening of neointima was not sup-
ported by the present results.
Remodeling of the arterial wall after injury to the
endothelial layer is a well-known process that leads to
thickening of the intima and a consequent decrease of the
inner diameter of the artery. Although one may hypoth-
esize that implantation of an epithelial cell lineage would
improve re-endothelialization, another line of reasoning
would be that implantation of a multipotent cell worsens
the situation because intima hyperplasia and transplanta-
tion are both anabolic processes. Although our ﬁeld of
regenerative medicine seeks to take advantage of the ﬁrst
hypothesis, we must be aware that sometimes the results
are not supporting the hypothesis, as in the present case.
Since injuring the carotid arteries causes signiﬁcant intima
thickening and reduce vascular function with only a mild
difference between the study groups, we cannot conclude
any correlation between cell transplantation and vascular
function in the present study model.
According to the recent data, muscle-derived stem
cells promote angiogenesis and improve perfusion on the
side of ischemia [27]. In addition, mesenchymal stem
cells reduce the formation of intima hyperplasia [28].
Although these adult stem cells are successfully used to
treat vascular injury, the main action of stem cells is not
through integration, differentiation, or tissue augmenta-
tion, but rather through paracrine mechanisms [29].
Transplanted hAECs, for instance, secrete proangiogenic
cytokines, and this paracrine effect could regenerate
myocardial tissue after myocardial infarction [30]. Im-
munosuppressive factors, which inhibit both the innate
and adaptive immune systems and are secreted by hAECs,
were also investigated in ocular surface inﬂammation [31]
showing the importance of paracrine mechanisms in
tissue regeneration.
Vascular biology is gaining attention in regenerative
medicine because the revascularization of the graft is the
bottleneck of implanting sizeable tissue constructs. The
presence of vessels canalizing the structures is the ﬁrst step
in the process; however, ample experimental and clinical
evidence show the active tone of the arteries is the main
determining factor in actual blood ﬂow. Although exper-
imental methods of the measurement of vascular function
are well established [32, 33], a few authors have used
these in a tissue engineering setting. Advancements in the
understanding of hAECs suggest that long-term survival
of the implanted cells, which were observed in intact
vessel walls, does not alter vascular function. This was
investigated and conﬁrmed in the present experiment.
We conclude that survival of the implanted cells and its
functional effectiveness are independent from each other
in this model. Although hAECs can incorporate into the
endothelial wall of artery without immunosuppression
and can also adhere far from damaged tissues, these cells
cannot use their positive effects to prevent intimal thick-
ening, showing that successful cell transplantation does
not necessarily improve functionality as well.
* * *
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Fig. 5. Long-term incorporation of hAECs into the vessel walls after balloon injury. Long-term cell survival and incorporation was observed on
the intact side in the cell transplanted group (Panel A). Red color represents the nuclear Hoechst staining and green color represents the
BrdU positive cells. Yellow color represents that Hoechst stained and BrdU positive cells are present in the intact side. This phenomenon
is not seen at the injured side (Panel B)
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